HUZHOU SIFENG BIOCHEM CO., LTD

A supplier's certificate of analysis can confirm what was tested in a Policosanol raw-material lot. It cannot, by itself, confirm the milligrams of Policosanol in each serving of a tablet, softgel or oil blend. That second number depends on a chain of decisions made after the ingredient arrives: the assay definition, weighed input, processing, representative sampling and a finished-product test suited to the actual formulation. For ingredient buyers, the useful question is where those records meet. The practical answer: qualify the ingredient and the finished product as two linked but separate measurements. A passing raw-material COA is the starting document; a validated per-serving result is the evidence for the finished product's declared amount. Why the gap deserves attention A 2025 study in Food Production, Processing and Nutrition measured five commercial Policosanol supplements sourced in Thailand and the United States. Only two contained the amount expected from their labels; the other three had lower measured amounts. The products were purchased in 2022, and the study did not test Sifeng Bio's SF-001 Policosanol. Nor did it establish one common cause for the differences. Its value here is narrower and more useful: it shows why a label claim should be checked in the final matrix rather than inferred from an ingredient specification. Policosanol is a mixture of long-chain primary alcohols. The defined set and measurement basis behind a reported “total Policosanol” figure matter; an individual alcohol such as octacosanol is a different analytical question. We explored that distinction in an earlier Policosanol–Octacosanol article. Here, the focus moves downstream to the amount that can actually be substantiated per serving. Five checkpoints between a COA and a label A workable qualification record follows the same material through five stages. Each stage answers a different question; none can substitute for the next one. CheckpointEvidence to retainDecision it supports 1. Incoming lotIdentity, source, lot number, defined assay, method and relevant contaminant limits.Can this specific ingredient lot be released against the agreed specification? 2. Formula inputTarget mg per serving, assay-adjusted input and documented weighing.Does the theoretical material balance match the proposed label amount? 3. ProcessingMixing sequence, hold conditions, transfer records and process yield.Did the process change distribution or recoverable amount? 4. Finished-product testRepresentative samples, matrix extraction, recovery and measured concentration.What amount is measured in the actual product and serving size? 5. Shelf-life reviewProduct-specific stability plan, packaging and time-point results.Does the declared amount remain supported over the proposed shelf life? One calculation, with a clear boundary Illustrative input calculation: if a hypothetical ingredient has a validated 95% w/w assay for the same defined Policosanol sum, a theoretical 10 mg of that sum requires 10 ÷ 0.95 ≈ 10.53 mg of ingredient per serving before manufacturing. This is a mass-balance example, not an SF-001 lot specification or an overage recommendation. It does not account for actual process loss, background Policosanol in other ingredients, sampling variation or analytical recovery. The finished product still needs its own measurement. A discrepancy after production can have several explanations: the input calculation or weighing, uneven distribution, a real processing change, unrepresentative sampling, or incomplete extraction during the analytical test. These are distinct hypotheses. Investigate them in sequence before declaring an ingredient lot at fault or raising the formula input. What the 2025 stability work does—and does not—show The same researchers studied a model of Policosanol-enriched rice bran oil, not every commercial dosage form. For the six-month storage arm, they used nitrogen-flushed amber glass bottles at an ambient 27 ± 5 °C. Under those conditions, the measured Policosanol level in the control oil and one enriched oil did not differ significantly from the initial level after six months, although intermediate readings varied. Heat experiments were separate. These details matter more than the shorthand “Policosanol is stable.” Use the paper to frame a test, not to assign a shelf life. Different oil systems, softgel shells, headspace, oxygen exposure, packaging, analytical methods and storage conditions call for product-specific work. The paper does not report the storage performance of SF-001 Policosanol or validate a buyer's finished formulation. A useful handoff for SF-001 Policosanol buyers HUZHOU SIFENG BIOCHEM CO., LTD lists SF-001 Policosanol (CAS 142583-61-7) on its English website. Before trial production, request a current written specification and a representative batch COA, then agree with the finished-product manufacturer on the analyte definition and method. The company's public pages currently display different grade ranges for SF-001; the current offer and lot documents should govern any commercial specification. Send a specification brief that can be answered State your intended dosage form and market, target Policosanol definition and per-serving amount, desired raw-material source, planned batch size, packaging conditions and the documents required for your qualification. Ask for the assay method and relevant homolog profile, then use pilot lots to agree on a finished-product test and acceptance criteria. For current SF-001 documentation and sample discussions: Policosanol product page · sales@sifengbio.com · +86-572-2576818 · Contact Sifeng Bio. Frequently asked questions What does a Policosanol raw-material COA establish for a finished-product label?A Policosanol COA reports results for a specified raw-material lot under a stated method. The finished product requires separate evidence for its measured Policosanol amount per serving in the actual matrix and, where relevant, over its shelf life. How should Policosanol input per serving be calculated from an ingredient assay?If the assay is a validated mass fraction for the same defined Policosanol sum used in the intended claim, divide the target mass by that fraction for a theoretical starting input. Confirm the basis and test the finished product; the calculation alone does not establish actual delivery. Why might measured Policosanol per serving differ from the Policosanol input calculation?Possible reasons include weighing, mixing and sampling variation, processing changes or incomplete analytical recovery from the final matrix. These possibilities require different checks. A lower measured result does not, by itself, identify the cause. Did the 2025 Policosanol supplement study test Sifeng Bio SF-001 Policosanol?No. The published study analysed selected commercial supplements and a rice-bran-oil model. It provides a reason to verify finished-product content, but its findings should not be attributed to Sifeng Bio SF-001 Policosanol. Can six-month rice-bran-oil results establish the shelf life of a Policosanol softgel?No. The cited six-month work used a specific oil model and nitrogen-flushed amber bottles under stated conditions. A Policosanol softgel has its own fill, shell, packaging and storage variables; its shelf life needs product-specific evidence. Which documents should a buyer request for SF-001 Policosanol qualification?Request the current SF-001 Policosanol specification and representative lot COA, the definition and method for the reported assay, origin and relevant homolog or impurity information, sample availability and documentation needed in the intended market. Confirm the actual offered grade because the public site lists differing ranges. How should a laboratory test Policosanol in a complex finished-product matrix?The laboratory should define the alcohols being summed, demonstrate identity and calibration, evaluate extraction recovery and repeatability in that specific matrix, and report the result in units that can be converted to mg per serving. The acceptance criteria should be agreed before routine release. Sources and verification Wongwaiwech et al., 2025, Food Production, Processing and Nutrition — commercial product measurements and the enriched-rice-bran-oil stability model; note its sample and storage conditions. Irmak et al., 2006, Food Chemistry — source-dependent Policosanol compositions. Sifeng Bio English homepage and SF-001 Policosanol product page — product identity and public catalogue information; confirm current grade numbers against the direct offer. Author statement: Prepared by HUZHOU SIFENG BIOCHEM CO., LTD for ingredient-industry communication. The cited commercial-product findings and oil stability data are independent research, not tests of Sifeng Bio materials or customer formulations. The calculation is a hypothetical example. This article makes no treatment claim and does not determine regulatory status or finished-product shelf life; validate the current lot specification and local requirements before use. Topics: #Policosanol   #IngredientQualification   #CertificateOfAnalysis   #FinishedProductTesting   #LabelClaim   #NutraceuticalFormulation   #BatchConsistency   #B2BSourcing {"@context":"https://schema.org","@graph":[ {"@type":"Organization","@id":"https://www.sifengbio.com/#organization","name":"HUZHOU SIFENG BIOCHEM CO., LTD","url":"https://www.sifengbio.com/","email":"sales@sifengbio.com","telephone":"+86-572-2576818"}, {"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sifengbio.com/"},{"@type":"ListItem","position":2,"name":"Industry News","item":"https://www.sifengbio.com/news_en/typeid/7.html"},{"@type":"ListItem","position":3,"name":"Policosanol on the COA vs Policosanol per Serving: Where Does the Number Change?","item":"https://www.sifengbio.com/news_detail_en/id/19.html"}]}, {"@type":"FAQPage","mainEntity":[ {"@type":"Question","name":"What does a Policosanol raw-material COA establish for a finished-product label?","acceptedAnswer":{"@type":"Answer","text":"A Policosanol COA reports results for a specified raw-material lot under a stated method. A finished product requires separate evidence for measured Policosanol per serving in its actual matrix."}}, {"@type":"Question","name":"How should Policosanol input per serving be calculated from an ingredient assay?","acceptedAnswer":{"@type":"Answer","text":"When the assay is a validated mass fraction for the same defined Policosanol sum, divide the target mass by that fraction for a theoretical input. Verify the result in the finished product."}}, {"@type":"Question","name":"Why might measured Policosanol per serving differ from the Policosanol input calculation?","acceptedAnswer":{"@type":"Answer","text":"Possible reasons include weighing, mixing and sampling variation, processing changes or incomplete analytical recovery in the finished matrix. Investigate each separately."}}, {"@type":"Question","name":"Did the 2025 Policosanol supplement study test Sifeng Bio SF-001 Policosanol?","acceptedAnswer":{"@type":"Answer","text":"No. The study tested selected commercial supplements and a rice-bran-oil model, not Sifeng Bio SF-001 Policosanol."}}, {"@type":"Question","name":"Can six-month rice-bran-oil results establish the shelf life of a Policosanol softgel?","acceptedAnswer":{"@type":"Answer","text":"No. The study used a specific oil model and nitrogen-flushed amber bottles. A Policosanol softgel needs product-specific stability evidence."}}, {"@type":"Question","name":"Which documents should a buyer request for SF-001 Policosanol qualification?","acceptedAnswer":{"@type":"Answer","text":"Request the current SF-001 Policosanol specification, representative lot COA, assay definition and method, origin and relevant composition information, and destination-market documents. Confirm the offered grade."}}, {"@type":"Question","name":"How should a laboratory test Policosanol in a complex finished-product matrix?","acceptedAnswer":{"@type":"Answer","text":"Define the alcohol sum, verify identity and calibration, assess extraction recovery and repeatability in the specific matrix, and report a result convertible to mg per serving."}} ]}, {"@type":"BlogPosting","headline":"Policosanol on the COA vs Policosanol per Serving: Where Does the Number Change?","url":"https://www.sifengbio.com/news_detail_en/id/19.html","mainEntityOfPage":"https://www.sifengbio.com/news_detail_en/id/19.html","datePublished":"2026-11-03","dateModified":"2026-11-03","description":"Follow Policosanol from raw-material COA to finished-product label with assay-adjusted input, matrix recovery, stability boundaries and buyer qualification questions.","image":["https://www.sifengbio.com/Public/userfiles/images/policosanol-coa-to-serving-1200x300.png","https://www.sifengbio.com/Public/userfiles/images/policosanol-qualification-1200x300.png"],"inLanguage":"en","author":{"@id":"https://www.sifengbio.com/#organization"},"publisher":{"@id":"https://www.sifengbio.com/#organization"},"keywords":["Policosanol","finished-product testing","ingredient COA","label claim","B2B sourcing"]} ]}

A 95% Policosanol offer and a 90% Octacosanol offer may look easy to rank. They are not the same measurement. Policosanol names a mixture of long-chain primary alcohols; Octacosanol is a specific C28 alcohol. Before comparing two percentages, an ingredient buyer needs to know what was measured, how it was measured, and what counted as 100%. Editorial illustration. Raw-material imagery does not identify the feedstock of a particular Sifeng Bio batch. First, name the substance behind the number SF-001 Policosanol Policosanol is a family of long-chain primary fatty alcohols, typically discussed through the combined assay and the relative profile of its members. The Sifeng Bio homepage lists 95%, 98% and 99% grades for SF-001. These catalogue figures do not disclose the individual C28 share or precise assay basis; confirm both against the current offer and batch COA. SF-002 Octacosanol Octacosanol (CAS 557-61-9) is the individual 28-carbon primary alcohol, also called 1-octacosanol. Sifeng Bio lists SF-002 grades of 10%, 12%, 40%, 50%, 60% and 90%; its product page separately describes a GC purity range and a total-alcohol indicator. Those lines answer different analytical questions. A percentage is incomplete until its denominator is clear The key distinction is between how much of the defined alcohol mixture is in the material and how much of the material is the C28 molecule. A third figure, the share of a C28 peak among identified alcohol peaks, describes the mixture's profile. These values can differ without any laboratory error. Reported line Question it may answer Clarify before comparing offers Total defined alcohols How much of the sample is the specified alcohol set? Included chain lengths, mass basis, calibration and exclusions. Octacosanol assay How much of the sample is C28 alcohol? Identity standard, GC method and whether the result is mass% or area%. Homolog distribution How is C28 distributed relative to C24, C26, C30 and other measured alcohols? Which peaks form the 100% reference and how unknowns are handled. For example, a label saying “90% Octacosanol” should not be silently read as “90% total alcohols,” or as “90% of the Policosanol mixture.” Likewise, a “95% Policosanol” listing does not disclose its C28 share. The test report must define the analyte and basis. A GC peak-area percentage also should not automatically be treated as weight percentage without a suitable quantitative method and calibration. Editorial illustration of analytical testing, not a photograph of Sifeng Bio's facility or its actual COA. Read the COA in a useful order Match the product and batch. Check SF-001 Policosanol or SF-002 Octacosanol, lot number, sampling date and the corresponding specification. Identify each assay line. Distinguish total defined alcohols, C28 content and the distribution of individual alcohols. Read the method note. Ask for GC conditions, reference standards, calculation basis and whether each number is area% or mass%. Review non-assay parameters. Residual solvents, moisture, heavy metals, microbiological limits and packaging can matter for the intended use. Compare more than one lot. A single COA describes one sample; repeatability across lots is a separate procurement question. Published analytical work on rice-bran-wax Policosanol used GC–MS for constituent identification and GC–FID with an internal standard for quantification. That is a useful illustration of why a chromatogram, calibration approach and defined sum can add meaning that a headline percentage lacks. It does not identify the method Sifeng Bio uses for any particular lot. Choose the grade for the application, not the largest number Ingredient development Define the target alcohol profile before screening Policosanol lots. A stated total alone does not describe the full mixture. Formula evaluation When the target is C28, compare Octacosanol assay with particle properties, processing conditions and performance in the actual formulation. Commercial supply Align a written specification, sampling plan, analytical method and destination-market documentation before moving from samples to recurring orders. No ingredient purity percentage, by itself, proves a finished product's efficacy, safety, regulatory status or suitability for a health claim. Those questions require separate evidence and market-specific review. Frequently asked questions What does 95% Policosanol mean for SF-001 Policosanol? The Sifeng Bio homepage lists a 95% SF-001 Policosanol grade, but that label alone does not define the precise alcohol set, assay basis or C28 share. Request the current SF-001 Policosanol specification and batch COA. Does 90% Octacosanol mean 90% total alcohols in SF-002 Octacosanol? No such equivalence should be assumed. The SF-002 Octacosanol product page presents Octacosanol purity and total alcohol content as separate indicators; confirm the method and calculation basis on the relevant SF-002 Octacosanol COA. Can 95% Policosanol be directly compared with 90% Octacosanol? A 95% Policosanol listing and a 90% Octacosanol listing may describe different analytes. Compare Policosanol total-alcohol definitions and homolog profiles with Octacosanol's C28 assay only after both specifications define the percentage basis. How are Policosanol and Octacosanol related in a GC profile? Octacosanol is a C28 primary alcohol that may appear as one constituent in a Policosanol mixture. A GC profile can separate Octacosanol from other measured Policosanol alcohols, subject to the validated method and identification standards. Which documents should a buyer request for SF-001 Policosanol and SF-002 Octacosanol? For SF-001 Policosanol and SF-002 Octacosanol, request the current specification, a batch COA, assay method description, identity or homolog data, relevant contaminant limits and documentation needed for the destination market. Does higher Octacosanol purity guarantee a better result than Policosanol? Higher Octacosanol assay does not establish that Octacosanol is better than Policosanol for every formulation. The desired molecule or mixture, delivery system, quality requirements and actual application tests should determine the choice. Compare a defined specification, then request a sample. Tell HUZHOU SIFENG BIOCHEM CO., LTD which grade, assay definition, intended application, destination market and expected volume you are evaluating. Ask for the current SF-001 Policosanol or SF-002 Octacosanol documentation before making a purchasing decision. Email: sales@sifengbio.com   |   Tel: +86-572-2576818   |   Website: www.sifengbio.com Sources and verification Sifeng Bio English homepage: SF-001 and SF-002 catalogue grades Sifeng Bio: SF-001 Policosanol product page; SF-002 Octacosanol product page Wang et al., Journal of Agricultural and Food Chemistry (2007): extraction methods and chromatographic fingerprint of rice-bran-wax Policosanol NIH PubChem: 1-Octacosanol identity and formula Author statement: Prepared by HUZHOU SIFENG BIOCHEM CO., LTD for ingredient-industry communication. Company-grade references come from its public website; analytical context comes from the cited research and chemical database. The article is educational and does not claim that either ingredient treats disease or that a listed purity figure guarantees a finished-product result. Confirm current specifications, batch documents and local requirements before use. Topics: #Policosanol   #Octacosanol   #FattyAlcohols   #IngredientQuality   #GCFID   #CertificateOfAnalysis   #NutraceuticalIngredients   #B2BSourcing {"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://www.sifengbio.com/#organization","name":"HUZHOU SIFENG BIOCHEM CO., LTD","url":"https://www.sifengbio.com/","email":"sales@sifengbio.com","telephone":"+86-572-2576818"},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sifengbio.com/"},{"@type":"ListItem","position":2,"name":"95% Policosanol vs 90% Octacosanol: What Does the Percentage Actually Measure?"}]},{"@type":"FAQPage","mainEntity":[{"@type":"Question","name":"What does 95% Policosanol mean for SF-001 Policosanol?","acceptedAnswer":{"@type":"Answer","text":"The Sifeng Bio homepage lists a 95% SF-001 Policosanol grade, but that label alone does not define the precise alcohol set, assay basis or C28 share. Request the current SF-001 Policosanol specification and batch COA."}},{"@type":"Question","name":"Does 90% Octacosanol mean 90% total alcohols in SF-002 Octacosanol?","acceptedAnswer":{"@type":"Answer","text":"No such equivalence should be assumed. The SF-002 Octacosanol product page presents Octacosanol purity and total alcohol content as separate indicators; confirm the method and calculation basis on the relevant SF-002 Octacosanol COA."}},{"@type":"Question","name":"Can 95% Policosanol be directly compared with 90% Octacosanol?","acceptedAnswer":{"@type":"Answer","text":"A 95% Policosanol listing and a 90% Octacosanol listing may describe different analytes. Compare Policosanol total-alcohol definitions and homolog profiles with Octacosanol's C28 assay only after both specifications define the percentage basis."}},{"@type":"Question","name":"How are Policosanol and Octacosanol related in a GC profile?","acceptedAnswer":{"@type":"Answer","text":"Octacosanol is a C28 primary alcohol that may appear as one constituent in a Policosanol mixture. A GC profile can separate Octacosanol from other measured Policosanol alcohols, subject to the validated method and identification standards."}},{"@type":"Question","name":"Which documents should a buyer request for SF-001 Policosanol and SF-002 Octacosanol?","acceptedAnswer":{"@type":"Answer","text":"For SF-001 Policosanol and SF-002 Octacosanol, request the current specification, a batch COA, assay method description, identity or homolog data, relevant contaminant limits and documentation needed for the destination market."}},{"@type":"Question","name":"Does higher Octacosanol purity guarantee a better result than Policosanol?","acceptedAnswer":{"@type":"Answer","text":"Higher Octacosanol assay does not establish that Octacosanol is better than Policosanol for every formulation. The desired molecule or mixture, delivery system, quality requirements and actual application tests should determine the choice."}}]},{"@type":"NewsArticle","headline":"95% Policosanol vs 90% Octacosanol: What Does the Percentage Actually Measure?","description":"Compare Policosanol and Octacosanol grades through assay definitions, C28 content, GC profiles and COA questions for ingredient sourcing.","image":["https://www.sifengbio.com/Public/userfiles/images/policosanol-octacosanol-grades.jpg","https://www.sifengbio.com/Public/userfiles/images/fatty-alcohol-gc-assay.jpg"],"datePublished":"2026-10-23","dateModified":"2026-10-23","inLanguage":"en","author":{"@id":"https://www.sifengbio.com/#organization"},"publisher":{"@id":"https://www.sifengbio.com/#organization"},"keywords":["Policosanol","Octacosanol","Fatty alcohols","GC-FID","COA","Ingredient sourcing"]}]}

Conclusion first: Hexacosanol, Octacosanol and Triacontanol are neighboring straight-chain primary fatty alcohols, but they are not interchangeable. From C26 to C28 to C30, only two carbons are added at each step, yet molecular weight, lipophilicity and melting behavior rise—changing processing and formulation choices. Same Functional Group, Different Chain Length Hexacosanol is C26H54O, Octacosanol is C28H58O, and Triacontanol is C30H62O. Each step adds C2H4 and about 28 g/mol. PubChem gives molecular weights of about 382.7, 410.8 and 438.8 g/mol. C26H54O → C28H58O → C30H62O Constant: one terminal hydroxyl group. Changing: chain length, molecular weight, hydrophobic contribution and crystal packing. Two Extra Carbons Shift Physical Behavior Property Hexacosanol Octacosanol Triacontanol Carbon number C26 C28 C30 CAS No. 506-52-5 557-61-9 593-50-0 Molecular weight 382.7 410.8 438.8 g/mol PubChem XLogP3 12.7 13.8 14.9 Polar surface area 20.2 Ų 20.2 Ų 20.2 Ų Representative TCI melting range* 78–81 °C 81–85 °C 85–90 °C The useful pattern is directional: the –OH head remains unchanged while the hydrocarbon chain grows. PubChem XLogP3 rises from 12.7 to 14.9 while polar surface area stays at 20.2 Ų, showing increasing lipophilic character from C26 → C30. *TCI values are representative grade specifications, not universal constants. Purity, homolog distribution and test method can shift an observed melting range. Why This Matters in Formulation Melting behavior affects melt incorporation, oil-phase dissolution and crystallization during cooling. Moving from C26 toward C30 may require a different thermal window or carrier system. In aqueous or semi-aqueous systems, particle size and emulsifier choice may matter as much as assay. Higher purity does not automatically mean easier formulation. Different Molecules, Different Application Logic Octacosanol is established as a nutritional/functional ingredient; Triacontanol is widely studied as a plant growth regulator; Hexacosanol is often evaluated as a homolog-specific high-carbon fatty alcohol. Their shared family does not imply the same formulation or qualification route. What Buyers Should Compare Beyond Purity Qualification logic: target-alcohol assay → homolog profile → GC method → melting range → source → residual controls → particle form → formulation compatibility → multi-batch consistency. Because neighboring C26/C28/C30 homologs are chemically similar, buyers should confirm whether a percentage refers to the target monomer or a broader total alcohol fraction. A headline purity value cannot replace a clear GC profile. Sifeng Bio's C26–C30 Platform HUZHOU SIFENG BIOCHEM CO., LTD states that its platform covers C24–C34 fatty alcohol monomers and mixtures. It lists Octacosanol SF-002 from 10% to 90%, Triacontanol SF-003 at 90% and 95%, and Hexacosanol at 90% and 95%. For sourcing, homolog control and application fit matter more than asking which carbon number is “better.” FAQ What is the main difference between Hexacosanol, Octacosanol and Triacontanol? Hexacosanol, Octacosanol and Triacontanol are C26, C28 and C30 linear primary fatty alcohols. Increasing chain length raises molecular weight, lipophilicity and, directionally, melting temperature. How do Hexacosanol, Octacosanol and Triacontanol differ in melting behavior? Representative TCI ranges are 78–81 °C for Hexacosanol, 81–85 °C for Octacosanol and 85–90 °C for Triacontanol. These are grade-specific ranges, not universal constants. Are Hexacosanol, Octacosanol and Triacontanol interchangeable in formulations? No. Hexacosanol, Octacosanol and Triacontanol differ in chain length, hydrophobicity and melting behavior, so solvent system, process temperature and dispersion strategy should be validated separately. How should B2B buyers compare Hexacosanol, Octacosanol and Triacontanol quality? Buyers comparing Hexacosanol, Octacosanol and Triacontanol should verify target-alcohol assay, homolog profile, GC method, melting range, residual controls and multi-batch consistency. Sources & Verification PubChem: Hexacosanol · Octacosanol · Triacontanol TCI melting-point references: C26 · C28 · C30 NIST Chemistry WebBook: 1-Hexacosanol · Octacosanol Comparing C26, C28 or C30? Share target alcohol, assay, application, annual volume and destination market before sample qualification. HUZHOU SIFENG BIOCHEM CO., LTD · sales@sifengbio.com

Conclusion first: Policosanol remains scientifically interesting, but the evidence is mixed. A 2025 systematic review identified 45 eligible studies; newer randomized data reported blood-pressure and lipid improvements, while earlier independent trials found no significant cholesterol benefit. The better question is which material, dose, population and study design produced the result? What the 2025 Review Really Shows The review screened 528 records and included 45 studies: 19 randomized trials, 9 comparative studies, 9 nutraceutical studies, while 8 reported no significant effect. Importantly, its search ended in April 2024, so newer 2025 hypertension data were not included. New 2025 Data Add a Blood-Pressure Signal In a Cuban multicenter trial, 200 prehypertensive participants received placebo or 20 mg/day sugarcane-wax alcohols for 12 weeks. 44% reached an SBP reduction ≥10 mmHg versus 7% with placebo. The Grade I hypertension stratum later reported 74% versus 12%. Evidence Key result Meaning 2025 systematic review 45 studies; positive and null findings Large but heterogeneous evidence base. 2025 prehypertension stratum 44% vs 7% reached ≥10 mmHg SBP reduction New positive signal. 2006 German RCT 143 patients; 10–80 mg/day; no lipid benefit vs placebo Results are not universally reproducible. Why the Cholesterol Evidence Is Still Contested A German randomized trial found no significant LDL-C benefit at 10–80 mg/day, and other independent studies also reported null lipid results. This challenges the idea that every “Policosanol” product is clinically interchangeable. Composition may contribute, but cannot explain everything. Policosanol is a mixture of long-chain primary alcohols, commonly including C24, C26, C28 and C30. Food Chemistry research showed source-dependent profiles and found some supplements containing less total Policosanol than claimed. What Ingredient Buyers Should Validate Better qualification rule: source + total alcohol assay + homolog profile + analytical method + residuals + multi-batch consistency + claim/regulatory review. This is why Octacosanol is not synonymous with Policosanol: C28 may be a major constituent, but Policosanol is a mixture. Compositional consistency therefore matters. Connecting the Evidence to SF-001 HUZHOU SIFENG BIOCHEM CO., LTD focuses on plant high-carbon fatty alcohols. Its SF-001 Policosanol is supplied under CAS 142583-61-7. Our related article on Policosanol, Octacosanol and Triacontanol explains why separation and homolog control matter in industrial production. FAQ What does the latest Policosanol clinical evidence say about cholesterol management? Policosanol clinical evidence remains mixed. A 2025 systematic review identified 45 studies with both positive and null findings, showing that results depend on study design, population, dose and material characteristics. Can Policosanol lower blood pressure according to 2025 research? Recent Policosanol research reported blood-pressure improvements in specific randomized trials using sugarcane-wax alcohols, but these findings should be interpreted together with earlier studies reporting different outcomes. Why do Policosanol products show different clinical results? Policosanol is a mixture of long-chain fatty alcohols rather than a single compound. Source, alcohol composition, analytical methods, dose and study population may influence reported outcomes. What should buyers check when sourcing Policosanol ingredients? Policosanol buyers should verify source, total alcohol assay, individual homolog profile, analytical method, residual controls, batch consistency and regulatory requirements for the intended application. What is new in 2025–2026? New Cuban randomized data reported blood-pressure and lipid improvements, but they should be read alongside earlier null trials. Why might products behave differently? Policosanol is a mixture, so source and alcohol composition can vary; this may contribute to variability but does not fully explain it. What should buyers verify? Source, total alcohol assay, homolog profile, analytical method, residuals and multi-batch consistency. Sources & Verification 2025 systematic review: ScienceDirect 2025 randomized data: Prehypertension · Grade I hypertension Independent null RCT: JAMA / PubMed · Composition study: Food Chemistry Qualifying a Policosanol Ingredient? Share your target source, analytical profile, annual volume and destination market. We can discuss SF-001 documentation and sample evaluation while keeping finished-product efficacy claims separate from raw-material specifications. HUZHOU SIFENG BIOCHEM CO., LTD · SF-001 Policosanol

Conclusion first: 2026 research is moving Triacontanol beyond the familiar “photosynthesis enhancer” story. New studies are probing soybean nodulation, antioxidant signaling, nutrient uptake and source-dependent biostimulant performance. The commercial lesson is equally important: equal assay does not guarantee equal biological response. Why Soybean Nodulation Matters Now A 2026 analysis of 31 U.S. studies estimated that biological N₂ fixation supplied about 53% of soybean nitrogen demand, versus roughly 62% required on average for a neutral nitrogen budget. That gap makes nodule efficiency a timely research target. 2026 Soybean Study: A Clear Dose Signal Researchers treated rhizobia-inoculated soybean roots with 0, 0.33, 0.5, 1 and 2 μg/mL Triacontanol. The 0.5 μg/mL treatment produced the highest nodule number at 14 and 28 days. Transcriptomics identified 867 differentially expressed genes, and follow-up work identified GmHSP26 as a positive regulator linked to Triacontanol-responsive nodulation and antioxidant activity. Signal Finding Buyer takeaway Dose 0.5 μg/mL performed best in this system More is not automatically better. Mechanism Antioxidant response + GmHSP26 Research is moving toward molecular evidence. Scope Controlled experiment Not a field-yield guarantee. Source and Processing Can Change Performance A June 2026 Frontiers in Plant Science study compared synthetic Triacontanol with two legume-derived extracts at an equivalent 2 mg/L dose in hydroponic rocket. Leaf fresh weight rose by 42%, 67% and 45%; the best-performing extract increased root fresh weight by 122%. SPAD values increased by about 24–34%. The same study found stronger Ca, Fe, P and S accumulation with the best-performing extract and concluded that extraction conditions and source matrix influenced biological response. For formulators, this is the key point: assay alone cannot fully predict efficacy. What Product Developers Should Validate 2026 qualification rule: identity → assay/homolog profile → analytical method → dispersion/formulation → crop-specific dose response → multi-batch consistency → field validation. The EU Fertilising Products Regulation defines plant biostimulants around nutrient-use efficiency, abiotic-stress tolerance, quality traits and nutrient availability. Triacontanol may fit product-development strategies around those outcomes, but the ingredient alone does not make a finished formulation compliant. Connecting the Research to SF-003 HUZHOU SIFENG BIOCHEM CO., LTD focuses on plant high-carbon fatty alcohols. Its SF-003 Triacontanol is published under CAS 593-50-0 in 90% and 95% specifications. Our related article on Policosanol, Octacosanol and Triacontanol discusses processing and formulation considerations. FAQ Does the soybean study prove field-yield gains? No. It shows a controlled nodulation mechanism; field performance still requires validation. Which soybean dose performed best? 0.5 μg/mL produced the highest nodule number in that experimental system. Why can source matter? A 2026 rocket study found different responses among synthetic and differently extracted materials at an equivalent dose. What should buyers validate? Identity, assay, homolog profile, analytical method, formulation behavior and multi-batch consistency. Sources & Verification Soybean nodulation: https://www.mdpi.com/2223-7747/15/10/1572 Triacontanol biostimulant study: https://www.frontiersin.org/journals/plant-science/articles/10.3389/fpls.2026.1847175/full Soybean N budget: https://www.nature.com/articles/s44264-026-00126-z EU definition: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex:32019R1009 Evaluate Triacontanol for a Real Formulation Share the target crop, delivery form, assay requirement and validation plan. We can discuss whether SF-003 90% or 95% is the more practical starting material for sample evaluation. HUZHOU SIFENG BIOCHEM CO., LTD · sales@sifengbio.com · Triacontanol SF-003

:root{--brand:#1f5f8f;--deep:#173d5e;--line:#d9e3eb;--soft:#f3f7fa;--ink:#293847;--muted:#617181} *{box-sizing:border-box} html,body{margin:0;width:100%;max-width:100%;overflow-x:hidden;background:#fff;color:var(--ink);font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",Roboto,Arial,sans-serif} .article{width:100%;margin:0;padding:34px 36px 50px} p{margin:0 0 19px;font-size:16px;line-height:1.9} a{color:#0b65a8;text-decoration:none;font-weight:600;overflow-wrap:anywhere} h2{position:relative;margin:42px 0 22px;padding:0 0 14px 17px;border-left:6px solid var(--brand);color:var(--deep);font-size:25px;line-height:1.45} h2:after{content:"";position:absolute;left:0;right:0;bottom:0;height:1px;background:var(--line)} .data-card,.note{margin:24px 0;padding:18px 20px;border:1px solid var(--line);border-left:5px solid var(--brand);border-radius:10px;background:var(--soft)} .note{border-left-color:#b78a32;background:#fffaf0} .table-wrap{width:100%;overflow-x:auto;margin:26px 0;border:1px solid var(--line);border-radius:10px;-webkit-overflow-scrolling:touch} table{width:100%;min-width:840px;border-collapse:collapse;font-size:14.5px} th,td{padding:13px 14px;border-bottom:1px solid var(--line);vertical-align:top;line-height:1.65;text-align:left} th{background:#eef3f7;color:#294863} tr:last-child td{border-bottom:none} .img-placeholder{margin:30px 0;padding:30px 20px;border:2px dashed #bccad5;border-radius:10px;background:#f8fafc;color:#687889;text-align:center;font-size:14px;line-height:1.8} .faq-grid{display:grid;grid-template-columns:repeat(2,minmax(0,1fr));gap:15px;margin:26px 0} .faq-card{padding:18px;border:1px solid var(--line);border-radius:10px;background:#fafbfd} .faq-q{font-weight:700;color:var(--deep);margin-bottom:10px;line-height:1.55} .faq-a{font-size:14.5px;line-height:1.8;color:#526273} .source{margin:10px 0;padding:12px 15px;border-left:4px solid #b9c8d5;background:#fafbfd;font-size:14px;line-height:1.7;color:#526273} .cta{margin-top:36px;padding:24px;border:1px solid #cfe0ec;border-radius:12px;background:linear-gradient(135deg,#eef7fc,#fbfdff)} .cta h3{margin:0 0 12px;color:var(--deep)} @media(max-width:760px){ .article{padding:22px 16px 36px} p{font-size:15px;line-height:1.88} h2{font-size:21px} .faq-grid{grid-template-columns:1fr} .table-wrap table{width:840px;min-width:840px} } { "@context": "https://schema.org", "@graph": [ { "@type": "Organization", "@id": "https://www.sifengbio.com/index_en.html#organization", "name": "HUZHOU SIFENG BIOCHEM CO., LTD", "url": "https://www.sifengbio.com/index_en.html" }, { "@type": "WebSite", "@id": "https://www.sifengbio.com/index_en.html#website", "url": "https://www.sifengbio.com/index_en.html", "name": "HUZHOU SIFENG BIOCHEM CO., LTD", "publisher": { "@id": "https://www.sifengbio.com/index_en.html#organization" }, "inLanguage": "en" }, { "@type": "BlogPosting", "headline": "Octacosanol Market Outlook 2025–2030: Global Demand Signals, Applications, Purity Grades, Bioavailability Challenges and Supply-Side Risks", "description": "2025–2030 Octacosanol market outlook covering market-size estimates, applications, purity grades, formulation challenges, bioavailability research and global supply.", "inLanguage": "en", "author": { "@id": "https://www.sifengbio.com/index_en.html#organization" }, "publisher": { "@id": "https://www.sifengbio.com/index_en.html#organization" }, "isPartOf": { "@id": "https://www.sifengbio.com/index_en.html#website" }, "keywords": [ "Octacosanol market 2025-2030", "Octacosanol market outlook", "Octacosanol purity grades", "Octacosanol bioavailability", "Octacosanol supplier" ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "What is a realistic 2025–2030 market size?", "acceptedAnswer": { "@type": "Answer", "text": "No single public consensus exists; use the roughly $116–194M 2025 range as directional evidence." } }, { "@type": "Question", "name": "Is 90% automatically better than 50% or 60%?", "acceptedAnswer": { "@type": "Answer", "text": "No. Application, analytical method, formulation route and delivered cost still matter." } }, { "@type": "Question", "name": "What is the main formulation challenge?", "acceptedAnswer": { "@type": "Answer", "text": "Low water solubility and bioavailability, which is why nanoemulsion and related delivery research is active." } }, { "@type": "Question", "name": "What should buyers validate?", "acceptedAnswer": { "@type": "Answer", "text": "Source, assay, homolog profile, residuals, particle properties, multi-batch consistency and destination-market documents." } } ] } ] } Conclusion first: Octacosanol demand is likely to expand through 2030, but no single public market-size figure is reliable enough to treat as consensus. Stronger signals are nutraceutical demand, new research and formulation work addressing low water solubility and bioavailability. Market Size: A Range Beats False Precision Public estimates diverge materially: Dataintelo gives $116.2M for 2025 and 6.8% CAGR; WiseGuyReports gives $194.2M for 2025 and 4.4%; Reports and Data gives $150M for 2024 and 7.5% to 2034. Source Base CAGR Implied 2030* Dataintelo $116.2M (2025) 6.8% ~$161M WiseGuyReports $194.2M (2025) 4.4% ~$241M Reports and Data $150M (2024) 7.5% ~$231M *Calculated from disclosed base values and CAGR, not a publisher consensus forecast. Market-reading rule: the 2025 public estimate range is already about 1.7× wide. Differences may reflect purity, source, geography or whether downstream products are included. Use these reports as directional evidence, not auditable demand tonnage. Applications and Research Signals Commercial reports place dietary supplements/nutraceuticals among the largest uses; one 2025 report estimates about 60% of 2024 demand. A July 2026 Molecules review examined cardiovascular-health research, while a 2025 Food Chemistry review covered anti-fatigue, anti-inflammatory, lipid-related and antioxidant research. These are research signals, not approved health claims. Purity Is Not the Whole Buying Decision Octacosanol is a C28 long-chain fatty alcohol commonly isolated from plant wax fractions. Higher purity can simplify impurity control, while intermediate grades may suit customers intentionally using broader long-chain alcohol fractions. Buyer check: assay method + homolog profile + source + residual solvents + moisture/volatiles + multi-batch consistency. Formulation Is the Main Technical Bottleneck The 2025 Food Chemistry review identifies poor bioavailability as a major limitation and highlights nanoemulsions, micelles, microcapsules and related delivery systems. A 2024 International Journal of Pharmaceutics study reported an O/W nanoemulsion with ~30 nm droplets, 60-day stability, 5.4× higher Caco-2 transport and 2.9× higher rat intestinal absorption than a suspension. Supply Outlook and Sifeng's Position Natural-source Octacosanol must be separated from similar C24–C34 alcohols, making fractionation and analytical repeatability important. HUZHOU SIFENG BIOCHEM CO., LTD publishes SF-002 grades of 10%, 12%, 40%, 50%, 60% and 90%, about 10 t/y Octacosanol capacity and 30 t/y broader C24–C34 alcohol capacity. Its technical article on Policosanol, Octacosanol and Triacontanol adds process context. FAQ What is a realistic 2025–2030 market size? No single public consensus exists; use the roughly $116–194M 2025 range as directional evidence. Is 90% automatically better than 50% or 60%? No. Application, analytical method, formulation route and delivered cost still matter. What is the main formulation challenge? Low water solubility and bioavailability, which is why nanoemulsion and related delivery research is active. What should buyers validate? Source, assay, homolog profile, residuals, particle properties, multi-batch consistency and destination-market documents. Sources & Verification Market estimates: Dataintelo · WiseGuyReports · Reports and Data. Scientific evidence: Food Chemistry 2025 review · Molecules 2026 review · 2024 nanoemulsion study. Discuss an Octacosanol Grade or Supply Qualification Share your target assay, annual volume, analytical requirements and destination market for grade discussion before sample validation. HUZHOU SIFENG BIOCHEM CO., LTD · sales@sifengbio.com      

Policosanol, Octacosanol, and Triacontanol are key aliphatic alcohols in bio-nutritional formulations. Industrial extraction requires thermodynamic modeling and crystallization control to overcome structural similarities in natural waxes and eliminate impurities. Properties and Scaling Metrics of Aliphatic Alcohol Monomers Separating C28 and C30 homologs during recovery remains a main challenge due to co-crystallization and low solubility in natural wax matrices. Governing Parameters: 1. Co-Crystallization: Free energy differentials require selective solvent pairs. 2. Mass Transfer: Higher carbon numbers increase melting points and reduce solubility. Item Product Name CAS No. Specs Key Scale-Up & Formulation Challenges SF-001 Policosanol 142583-61-7 95% - 99% Maintaining precise constituent alcohol ratios at industrial scale. SF-002 Octacosanol 557-61-9 10% - 90% Preventing thermal cracking during high-vacuum distillation. SF-003 TRIACONTANOL 593-50-0 90%; 95% High hydrophobicity; requires micronization for dispersion stability. 1. Phase Separation and Purity Optimization Reaching high purity relies on multi-stage fractional crystallization. Controlled cooling and targeted reflux decouple nucleation from crystal growth, enabling clean filtration. Literature References: • Small, D. M. (1986). The Physical Chemistry of Lipids. Plenum Press. • Phase Transitions of C28/C30. J. Agric. Food Chem., 62(14), 3211-3220. Advanced Protection and Downstream Integration 1. Thermal Protection and Viscosity Control High-vacuum distillation of Triacontanol increases fluid viscosity. Wiped film evaporators shorten residence times to seconds, eliminating local overheating and thermal degradation. 2. Micronization for Enhanced Bioavailability Jet milling and high-pressure homogenization reduce hydrophobic particle sizes to sub-micron levels, preventing grittiness in topical formulations and improving powder blending uniformity. Processing & Application FAQ Q: How does Octacosanol purity affect formulation shelf-life? A: High-purity grades prevent lipid peroxidation. Lower grades contain residual waxes that undergo rancidity. Q: What governs solvent selection for Triacontanol? A: Steep temperature-solubility gradients—minimal solubility at ambient temperature and high solubility near boiling. Q: Why are homolog ratios critical in Policosanol? A: Regulatory monographs define Policosanol by precise alcohol ratios to ensure consistent bio-efficacy. HUZHOU SIFENG BIOCHEM CO., LTD | Bio-Extraction Leader Established in 2003, HUZHOU SIFENG BIOCHEM CO., LTD is a top 3 Chinese manufacturer of high-purity plant extracts, offering full traceability from raw intake to delivery. Core Portfolio: • Aliphatic Alcohols: Policosanol (95-99%), Octacosanol (10-90%), Triacontanol (90-95%). • Bio-Extracts: Microalgae DHA, Pearl Powders, Silk Amino Acids & Peptides. Proprietary Patents: Octacosanol Process (CN103232320B) & Myricetin Process (CN101838255B).

Conclusion first: High-quality Octacosanol production depends largely on extraction and purification technology. A stable manufacturing process is essential because natural plant materials vary significantly and directly influence final ingredient consistency. Why Octacosanol Extraction Technology Matters? Natural Octacosanol is mainly obtained from plant wax fractions. Unlike simple chemical synthesis, botanical extraction requires careful separation of target compounds from complex natural matrices. For supplement manufacturers, extraction technology determines not only purity, but also reproducibility, impurity control and commercial scalability. Key Challenges in Industrial Octacosanol Production Challenge Impact Raw material variation May influence active ingredient content. Purification efficiency Determines final purity and consistency. Batch control Critical for global supplement brands. From Extraction to High-Purity Ingredient A professional production process normally includes raw material preparation, extraction, separation, purification and analytical verification. Each stage contributes to final product quality. Sifeng Bio Technology Capability HUZHOU SIFENG BIOCHEM CO., LTD focuses on high-purity plant extracts. The company owns the Octacosanol Production Process Patent CN103232320B and serves global health supplement and cosmetic industries. Product collection: Plant Extract Ingredients FAQ Q1: Why is extraction technology important? A: It directly affects purity, stability and batch consistency. Q2: What makes botanical ingredients difficult to standardize? A: Natural raw materials can vary due to source and processing conditions. Q3: Why should buyers evaluate manufacturers instead of only products? A: Long-term supply requires stable processes and quality systems. Contact Us Email: sales@sifengbio.com Website: https://www.sifengbio.com/ Author Statement This article was prepared by HUZHOU SIFENG BIOCHEM CO., LTD for industry communication. Technical information is based on publicly available scientific references and industry materials. Company information is based on publicly available company sources. This content is for knowledge sharing only and does not constitute specific technical guidance or purchasing advice.